- 专利标题: ANTI-CANCER ONCOLYTIC VIRUS COMBINATION THERAPIES AND ELITE RESPONDER SELECTION PLATFORMS
-
申请号: US15744295申请日: 2017-03-28
-
公开(公告)号: US20190000899A1公开(公告)日: 2019-01-03
- 发明人: Minjie HU , Yu LI , Xiaoling LIU , Rebecca HU
- 申请人: Minjie HU , Yu LI , Xiaoling LIU , Rebecca HU
- 国际申请: PCT/US2017/024471 WO 20170328
- 主分类号: A61K35/768
- IPC分类号: A61K35/768 ; A61P35/00 ; A61K39/39 ; A61K35/745
摘要:
Therapeutic methods for administering gut microbiota and oncolytic viruses to a subject are provided. The gut microbiota serve to pre-condition, the subject's immune system to antitumor responses and augments anticancer activity of the oncolytic vims. Combinations of the gut. microbiota and viruses and uses thereof for treating and preventing cancer are provided. The present disclosure also provides methods for building elite responder selection platforms through hierarchical clustering analysis of genomic profiles for human gut microbiome.
公开/授权文献
信息查询
IPC分类: